282 related articles for article (PubMed ID: 12227071)
1. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction].
Kaledin VI; Popova NA; Andreeva EM
Vopr Onkol; 2006; 52(1):70-3. PubMed ID: 16715708
[TBL] [Abstract][Full Text] [Related]
3. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
5. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
6. [Morphological estimation of apoptosis in preclinical studies of new drugs].
Karpova GV; Timina EA; Karpova MR
Eksp Klin Farmakol; 2000; 63(6):62-3. PubMed ID: 11202516
[TBL] [Abstract][Full Text] [Related]
7. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
8. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
[TBL] [Abstract][Full Text] [Related]
9. Animal model of drug-resistant tumor progression.
Mironova N; Shklyaeva O; Andreeva E; Popova N; Kaledin V; Nikolin V; Vlassov V; Zenkova M
Ann N Y Acad Sci; 2006 Dec; 1091():490-500. PubMed ID: 17341638
[TBL] [Abstract][Full Text] [Related]
10. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
[TBL] [Abstract][Full Text] [Related]
11. Effects of the chemotherapeutic agents for non-Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome.
Vaisheva F; Delbes G; Hales BF; Robaire B
J Androl; 2007; 28(4):578-87. PubMed ID: 17409468
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
13. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H; Hibi T
Anticancer Res; 2004; 24(6):3723-30. PubMed ID: 15736403
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
16. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
Bernacki RJ; Bansal SK; Gurtoo HL
Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic treatment of xenograft Spirocerca lupi-associated sarcoma in a murine model.
Stettner N; Ranen E; Dank G; Lavy E; Brenner O; Harmelin A
Comp Med; 2007 Jun; 57(3):267-71. PubMed ID: 17605341
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells.
Suzuki H; Hotta T; Koyama T; Komagata M; Imakiire A; Yanase N; Yoshimoto T; Mizuguchi J
Anticancer Res; 2003; 23(4):3247-53. PubMed ID: 12926060
[TBL] [Abstract][Full Text] [Related]
19. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of tumor-associated endothelial cell apoptosis by the novel vascular-targeting agent ZD6126 in combination with cisplatin.
Goto H; Yano S; Matsumori Y; Ogawa H; Blakey DC; Sone S
Clin Cancer Res; 2004 Nov; 10(22):7671-6. PubMed ID: 15570000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]